🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Spyre Therapeutics, Inc.

SYRE Healthcare
$93.47 $-4.16 (-4.26%)
Market Cap: $8.88 B
Gurus Holding
2
Popularity Rank
#3566
% of Shares Held
0.40%
Net Activity (Q3 2026)
+$26.98 M

Guru Ownership Trend

Guru Analysis for Spyre Therapeutics, Inc. (SYRE)

Spyre Therapeutics, Inc. (SYRE), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q3 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $35.54 M.

Top institutional holders include Steven Cohen and Cliff Asness.

Institutional sentiment is currently Bullish. This is evidenced by a $26.98 M net inflow during the quarter.

Recent activity highlights Steven Cohen who opened a new position.

Key Holders

Top 5 by Value

$31.78 M
$2.08 M

Top 5 by Conviction

Recent Activity Breakdown (Q3 2026)

+$31.81 M
Total Buy Value
New Buys 1
Additions 1
-$4.83 M
Total Sell Value
Reductions 0
Sold Out 2

Guru Consensus (Q3 2026)

Based on recent activity
Net Sellers
2
Net Buyers
2

FAQs for Spyre Therapeutics, Inc. (SYRE)

Major holders include Steven Cohen ($31.78 M), Cliff Asness ($2.08 M). According to the latest reported data, 2 tracked investment managers collectively hold approximately 380,231 shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $26.98 M, with 2 managers increasing positions and 2 managers reducing holdings.

During the most recent reporting period, 0 managers trimmed their positions, while 2 fully exited SYRE. The total reported sell value was $4.83 M.

Yes, 1 managers opened new positions in SYRE, and 1 increased their existing holdings. The total reported buy value was $31.81 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.04% New Buy 356,923 $31.78 M Q3 2026
0.00% Add 1.6% 23,308 $2.08 M Q3 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form